We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

AI-Powered Cervical Cell Analysis System Aids Early Cancer Detection

By LabMedica International staff writers
Posted on 27 Oct 2023
Print article
Image: The miLab Cartridge CER uses cervical cytology as a screening method (Photo courtesy of Noul)
Image: The miLab Cartridge CER uses cervical cytology as a screening method (Photo courtesy of Noul)

A novel cervical cell analysis product helps overcome the limitations of Human Papillomavirus (HPV) testing by offering detailed insights into the stages of cervical pre-cancer and cancer, using cervical cytology as a screening method.

Noul Co., Ltd. (Yongin, South Korea) launched its miLab Cartridge CER, a specialized device for automatically staining and evaluating cervical cells. The cervical cell analysis product works on samples from cervico-vaginal smears, either manually prepared or using liquid-based cytology (LBC). It employs the Papanicolaou staining method, enhanced by Next Generation Staining and Immunostaining (NGSI), a proprietary staining technology developed by Noul. When paired with Noul's AI-driven diagnostic system, miLab, it provides staining, imaging, and cellular analysis results that aid in making diagnostic decisions.

The miLab Cartridge CER leverages cervical cytology for screening and is capable of identifying the detailed stages of cervical pre-cancer and cancer. This is achieved through AI-based morphological analysis, a key advantage offered by the miLab platform. Additionally, the product speeds up the total time for testing, making it easier for users to survey the entire sample area, differentiate between cells that are negative or positive for cancer, and focus on the cells most relevant for diagnosis. Noul received the CE mark for the miLab Cartridge CER in August 2022 and the CE-IVDR certification for the miLab platform in February 2023.

"Through the launch of cervical cell analysis products, we have made a real step forward in the cancer diagnostic business,” said David Lim, CEO of Noul. “The miLab Cartridge CER is compatible with both PAP smear and LBC methods, and it enables efficient and accurate cervical cell review with the full automatic staining and analysis. We want to contribute to the early diagnosis of cervical cancer, the fourth largest cancer in the world for women."

Related Links:
Noul Co., Ltd. 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
POCT Fluorescent Immunoassay Analyzer
Gold Member
Real-time PCR System
GentierX3 Series

Print article


Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more


view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more


view channel
Image: A false color scanning election micrograph of lung cancer cells grown in culture (Photo courtesy of Anne Weston)

AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell

Current strategies for matching cancer patients with specific treatments often depend on bulk sequencing of tumor DNA and RNA, which provides an average profile from all cells within a tumor sample.... Read more


view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.